Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-14 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +6,250 $8.93 $56K 57,830
2026-04-14 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +6,500 $20.46 $133K 64,330
2026-04-14 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −21,977 $41.07 $903K 42,353
2026-04-14 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −2,500 5,000
2026-04-14 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −6,250 12,500
2026-04-14 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −6,500 19,500
2026-04-14 Baynes Roy D. Director Option exercise 10b5-1 +8,000 $17.94 $144K 45,500
2026-04-14 Baynes Roy D. Director Option exercise 10b5-1 +9,000 $15.43 $139K 54,500
2026-04-14 Baynes Roy D. Director Option exercise 10b5-1 +4,500 $18.27 $82K 59,000
2026-04-14 Baynes Roy D. Director Option exercise 10b5-1 +4,500 $21.38 $96K 63,500
2026-04-14 Baynes Roy D. Director Option exercise 10b5-1 +6,750 $17.11 $115K 70,250
2026-04-14 Baynes Roy D. Director Sale 10b5-1 −26,000 $41.07 $1.1M 44,250
2026-04-14 Baynes Roy D. Director Sale 10b5-1 −6,750 $42.12 $284K 37,500
2026-04-14 Baynes Roy D. Director Option exercise · Stock option (right to buy) 10b5-1 −8,000 0
2026-04-14 Baynes Roy D. Director Option exercise · Stock option (right to buy) 10b5-1 −9,000 0
2026-04-14 Baynes Roy D. Director Option exercise · Stock option (right to buy) 10b5-1 −4,500 4,500
2026-04-14 Baynes Roy D. Director Option exercise · Stock option (right to buy) 10b5-1 −4,500 4,500
2026-04-14 Baynes Roy D. Director Option exercise · Stock option (right to buy) 10b5-1 −6,750 6,750
2026-04-14 LYONS GARY A Director Option exercise 10b5-1 +8,000 $16.33 $131K 65,500
2026-04-14 LYONS GARY A Director Sale 10b5-1 −8,000 $41.07 $329K 57,500

Page 10 of 51 · 1,020 trades